Coherus Oncology
CHRS
CHRS
163 hedge funds and large institutions have $536M invested in Coherus Oncology in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 65 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $623M → $536M (-$86.2M)
29% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 65
Holders
163
Holding in Top 10
–
Calls
$1.04M
Puts
$372K
Top Buyers
| 1 | +$3.92M | |
| 2 | +$3.72M | |
| 3 | +$2.16M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.91M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.29M |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$3.57M | |
| 3 | -$3.14M | |
| 4 |
Millennium Management
New York
|
-$2.22M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.96M |